BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-693@pharmaconomics
DTSTAMP:20260707T021848Z
DTSTART;VALUE=DATE:20260624
DTEND;VALUE=DATE:20260625
SUMMARY:IONS Approval — TRYNGOLZA
DESCRIPTION:A final FDA approval decision on TRYNGOLZA for severe hypertriglyceridemia is expected Jun 24\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/874015/000114036126026232/ef20076807_8k.htm\n\nTrack it: https://www.pharmaconomics.com/e/693
URL:https://www.pharmaconomics.com/e/693
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:IONS catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR